Convalescent plasma

Randomised Evaluation of COVID-19 Therapy

Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection

Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation

Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Convalescent Plasma Therapy for Hospitalized Patients With COVID-19

Phase 3 Open-Label Controlled Trial of Convalescent Plasma in Early COVID-19 Infection

Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection

Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection

Convalescent Plasma in Hospitalized COVID-19 Patients

Experimental Expanded Access Treatment With Convalescent Plasma for the Treatment of Patients With COVID-19

Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19

Arkansas Expanded Access COVID-19 Convalescent Plasma Treatment Program

COVID-19 Infection in Patients Receiving Anti-CD20 Therapy

CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients

Use of Convalescent Plasma for COVID-19

Passive Immunotherapy In Patients With SARS CoV-2

Expanded Access to Convalescent Plasma for Treatment of COVID-19

VA CoronavirUs Research and Efficacy Studies-1

Treatment of Patients With COVID-19 With Convalescent Plasma